The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …

Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …

Abstract Background Mural nodules (MNs) have a predominant role in the 2016 revision of
the international guidelines on intraductal papillary mucinous neoplasms (IPMN) of the …

Pancreatic ductal adenocarcinoma (PDAC) may arise from intraductal papillary mucinous
neoplasms (IPMN) with malignant transformation, but a significant portion of IPMN remains …

Objective: To create a simple, objective model to predict the presence of malignancy in
patients with intraductal papillary mucinous neoplasm (IPMN), which can be easily applied …

Background Significant overtreatment of intraductal papillary mucinous neoplasms can be
attributed to low specificity of the current International Consensus Guidelines as well as …

OBJECTIVE. The purpose of this article is to review a spectrum of calcified pancreatic
masses and propose an algorithm for diagnostic radiologic evaluation. CONCLUSION …

Background Detection of cystic lesions of the pancreas has outpaced our ability to stratify
low-grade cystic lesions from those at greater risk for pancreatic cancer, raising a concern …

Background The association between risk of pancreatic cancer and a dilated main
pancreatic duct (MPD) in intraductal papillary mucinous neoplasm (IPMN) is debated. The …

Simple Summary Currently, there are several guidelines that are widely used to establish
the treatment strategy for branch duct type intraductal papillary mucinous neoplasms …